Jens Klein

hanse chemie AG manufactures and markets silicone based raw materials. It provides materials for sealants & adhesives, formulations, and polymers for automotive applications. The company was founded in 1985 and is headquartered in Geesthacht, Italy.

German Ventures investing in the startup companies, It was founded in 2013 by Thomas Bernik, Serial Entrepreneur and Investor and Jens Klein. The firm Headquartered in Germany.

Insempra GmbH is a German biology-powered company that combines bioscience and technology to grow matter for new and better products. The company is based in Planegg, Germany. The company enables businesses to make superior products with nature, aiming to restore the balance between people and the planet. Insempra is committed to driving the regenerative revolution to manufacture at scale in collaboration with nature. The company was founded by Andreas Heyl, Jens Klein. Jens Klein has been the CEO since incorporation.

Solena Materials Ltd. is a protein materials design British company that uses computational design, machine learning, and automation to develop bespoke materials for various sectors, including fashion apparel and medical textiles. The private company is based in London, UK. The company's protein-based fibers aim to replace materials extracted from nature and petrochemically-derived materials to create biodegradable, functional, and sustainable smart materials. The company was founded in 2021 by Jens Klein and James Tomomi Macdonald, with Jens Klein serving as the CEO since then.

AMSilk GmbH engages in the production of fiber and biopolymers.It offers implant coating, medical devices for OTC wound care, functional cosmetics, cell biology device kits, biosteel spidersilk fibers and spidersilk research license. It serves the biosteel fibers, medical devices, and cosmetic ingredients industry. The firm's materials are to be applied in numerous fields to improve existing products or to develop materials for completely new applications, which could not be realized until now due to the lack of an appropriate material. The company was founded by Axel H. Leimer, Thomas Scheibel, and Lin Römer in 2008 and is headquartered in Planegg, Germany.

Mulligan BioCapital GmbH operates as an investment firm for the biotechnology area. It engages in the sciences industry and provides health care applications. The company was founded on November 2, 2007 and is headquartered in Hamburg, Germany.